Home Combat Arthritis Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Nov 21, 2020 comments off

Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Arthritis drug baricitinib is authorised for emergency use in combination remdesivir to treat COVID-19 patients.

Read More…

You May Also Like

Over 20 Metro products sold in Ontario recalled due to possible salmonella – OttawaMatters.com

Why North Korean Leader Kim Jong Un's Weight Gain is Closely Monitored

Different outcomes by race/ethnicity among patients with COVID-19 and rheumatic disease

Shielding: Vulnerable people sent emails by government just hours before start of second lockdown – St Helens Star

COVID-19 patients are developing ‘brain fog.’ But what does that mean?

FDA Authorizes Arthritis Drug Combo for COVID-19